FDA
approval
· 2023-04-05
FDA Approved: BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% — Original Application (Alembic Pharmaceuticals Limited)
Summary
FDA approved BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% from Alembic Pharmaceuticals as an original application for the treatment of itching associated with …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5% (BEPOTASTINE BESILATE OPHTHALMIC SOLUTION 1.5%)